Order Stem Cells
- - - Over 1500+ diverse stem cell lines
      
      WiCell provides over 1500 diverse cell lines including hESC, iPSC, and cGMP cell lines. Search the catalog to find the right cell line for your research.
      
      Learn More
Test Cells
- - - cGMP and research grade testing services
      
      Reliable cGMP and research testing for a variety of stem, immune, and engineered cell types. From bench to clinic, we provide quality assays and quick turn around times to support your needs.
      
      Learn More
Store Cells
Other Services
- - - Let WiCell be your lab partner
      
      Backed by decades of experience and a commitment to quality, WiCell is your lab partner for banking, distribution, and reagent testing, letting you focus on the science while we take care of the rest.
      
      Learn More
Resources
- - - Trusted knowledge. Proven science.
      
      Insights, publications, and updates from WiCell’s team of experts. Whether you’re looking for technical guidance or the latest news, our resources are here to support your research every step of the way.
      
      Learn More
About Us
- - - Built on trust
      
      For over two decades, WiCell has earned the trust of the scientific community through expertise, integrity, and our unending commitment to quality.
      
      Learn More
- - - Search for:

NHLBI Next Gen - Coronary artery disease and myocardial infarction (Dr. Eric Topol, Scripps Research Institute)

NHLBI Next Gen - Coronary artery disease and myocardial infarction (Dr. Eric Topol, Scripps Research Institute)

Showing 49–64 of 97 results

Cell Line	Cell Line Alias	Cell Type	Disease	Genetic Alteration/Mutation	Sex	Age at Collection	Ethnicity	Genetically Related Cell Lines	dbGaP Data
SCRP2211i	KBET2211i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Female	95 Years	Caucasian > European	No	No
SCRP2305i	KBET2305i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites.	Male	86 Years	Caucasian > European	No	No
SCRP2306i	C00498	Human iPS	Coronary artery disease	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites.	Male	82 Years	Caucasian	No	No
SCRP2307i	KBET2307i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites.	Male	86 Years	Caucasian > European	No	No
SCRP2310i	KBET2310i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the non-risk alleles at all 3 sites.	Male	86 Years	Caucasian > European	No	No
SCRP2407i	KBET2407i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Male	100 Years	Caucasian > European	No	No
SCRP2409i	KBET2409i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Male	100 Years	Caucasian > European	No	No
SCRP2411i	KBET2411i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Male	100 Years	Caucasian > European	No	No
SCRP2501i	C00510	Human iPS	Coronary artery disease\|Myocardial infarction	Three sites within the 9p21 region were genotyped for each donor. This donor was heterozygous for the risk and non-risk alleles at all 3 sites.	Male	73 Years	Caucasian > European	No	No
SCRP2503i	KBET2503i	Human iPS	None reported	Three sites within the 9p21 region were genotyped for each donor. This donor was homozygous for the risk alleles at all 3 sites.	Male	87 Years	Caucasian > European	No	No

1…345…10